1. Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11:165–223.
2. McDermot PA. Diabetic emergencies and sick day rules. Home Care
Provid. 1998;3:298–301.
3. Eledrisi MS, Elzouki AN. Management of diabetic ketoacidosis in adults: a
narrative review. Saudi J Med Med Sci. 2020;8:165.
4. Guisado-Vasco P, Cano-Megías M, Carrasco-de la Fuente M, CorresGonzález J, Matei AM, González-Albarrán O. Clinical features, mortality,
hospital admission, and length of stay of a cohort of adult patients with
diabetic ketoacidosis attending the emergency room of a tertiary hospital in Spain. Endocrinol Nutr. 2015;62:277–84.
5. American Diabetes Association. Treatment & care, preparing for sick-days.
https://www.diabetes.org/diabetes/treatment-care/planning-Sick-days.
Accessed 14 Mar 2022.
6. International Diabetes Federation. How to manage diabetes during an
illness? Sick-day rules. https://www.idf.org. Accessed 14 Mar 2022.
7. Laffel LM, Limbert C, Phelan H, Virmani A, Wood J, Hofer SE. ISPAD
Clinical Practice Consensus Guidelines 2018: sick day management in children and adolescents with diabetes. Pediatr Diabetes.
2018;19:193–204.
8. Pichert JW, Snyder GM, Kinzer CK, Boswell EJ. Problem solving
anchored instruction about sick days for adolescents with diabetes.
Patient Educ Couns. 1994;23:115–24.
Page 10 of 10
9. Association of Diabetes Care & Education Specialist. https://www.diabe
teseducator.org/docs/default-source/education-and-career/Sick-day_
adult.pdf?sfvrsn=2. Accessed 14 Mar 2022.
10. Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a
review. Curr Diabetes Rev. 2017;13:315–21.
11. Musso G, Saba F, Cassader M, Gambino R. Diabetic ketoacidosis with
SGLT2 inhibitors. BMJ. 2020. https://doi.org/10.1136/bmj.m4147.
12. Wiedenmayer K, Summers RS, Mackie CA, Gous AGS, Everard M. Developing pharmacy practice: a focus on patient care [Handbook]. 2006. https://
apps.who.int/iris/handle/10665/69399. Accessed 14 March 2022.
13. Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist
intervention on glycemic control in diabetes. Diabetes Res Clin Pract.
2011;92:145–52.
14. Hazen ACM, de Bont AA, Boelman L, Zwart DL, De Gier JJ, De Wit NJ,
et al. The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: a systematic
review. Res Social Adm Pharm. 2018;14:228–40.
15. Steed L, Sohanpal R, Todd A, Madurasinghe VW, Rivas C, Edwards EA,
et al. Community pharmacy interventions for health promotion: effects
on professional practice and health outcomes. Cochrane Database Syst
Rev. 2019;12:CD011207.
16. Diabetes net. [Tonyobyou Network in Japanese] 6% of people with
diabetes experience sick-days, but their awareness is low. [TonyobyouKanjasanno 6wariga shikkudei wo taikensurumo Ninchihikui]. 2012.
https://dm-net.co.jp/calendar/2012/018565.php. Accessed 14 Mar 2022.
17. Japan Cabinet Office [internet]. Annual report on the aging society
FY2020 [cited 14 Mar 2022]. Available from: https://www8.cao.go.jp/
kourei/english/annualrepor t/2020/pdf/2020.pdf.
18. Organization for Economic Co-operation and Development (OECD).
Elderly population. https://data.oecd.org/pop/elderly-population.htm.
Accessed 14 Mar 2022.
19. Japan Ministry of Health, Labour and Welfare. Information on pharmacies and pharmacists [Yakkyoku, Yakuzaisi ni kansurujouho]. https://
www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/
yakkyoku_yakuzai/index.html. Accessed 14 Mar 2022.
20. Tachi T, Noguchi Y, Teramachi H. Developing and verifying the efficacy
of “Educational Program for Promoting Appropriate Self-Medication via
Pharmacies and Pharmacists”: a randomized controlled trial. Biol Pharm
Bull. 2020;43:77–86.
21. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of
health promotion interventions: the RE-AIM framework. Am J Public
Health. 1999;89:1322–7.
22. RE-AIM. https://re-aim.org/. Accessed 14 Mar 2022.
23. Onda M, Kuwanoe T, Hashimoto A, Horiguchi M, Domichi M, Sakane N.
Pharmacist-delivered Smoking Cessation program in community pharmacy (the FINE program) in Japan-the development of a training course
and a feasibility study. J Pharm Pract. 2021;34:625–30.
24. Japan Pharmaceutical Association, Japan Pharmaceutical Diabetes Society. Diabetes care guideline by pharmacist [Yakuzaishiniyoru Tounyoubyshinryo Guideline in Japanese]. Tokyo: Jiho; 2018.
25. Kanda Y. Investigation of the freely available easy-to-use software “EZR”
for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
26. Japan Pharmaceutical Diabetes Society. https://jpds.or.jp/. Accessed 14
Mar 2022
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
...
論文の公開元へ
